Anton Gueth, Director at Antares Pharma, holds 467.58K shares in Antares Pharma (Ticker: ATRS), holds 38.92K shares in Navidea (Ticker: NAVB), holds 11.00K shares in Spectrum Pharmaceuticals (Ticker: SPPI).

See the Hottest Stocks Based on Insider Trading >

Anton Gueth
Antares Pharma (ATRS)
Director

Ranked #5,861 out of 98,501 Corporate Insiders

Profitable Transactions

3 out of 4 Profitable Transactions

Average Return

+84.30%

Average return per transaction

Time Frame

1 Year

Compare to

No Benchmark

How are Insiders Ranked?

Insider Holdings

100.00%

NAVB

A breakdown of Anton Gueth's holdings

See the Top Stocks by Insiders

Insider Roles

Navidea
(NAVB)

Director

Roles that Anton Gueth holds in companies

See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:

Antares Pharma
(ATRS)

Rating:Informative Buy

Date:Mar 21, 2016 - Mar 21, 2017

Return:+231.60%

The most profitable trade made by Anton Gueth

See the Latest Stocks Traded by Insiders

Anton Gueth's Trading History

ATRS

Antares Pharma

Jul 09, 2021

―

Uninformative Sell

429.00K

$2.61M

NAVB

Navidea

Jan 08, 2016

Director

Uninformative Buy

20.64K

$1.36K

SPPI

Spectrum Pharmaceuticals

Dec 21, 2012

―

Uninformative Buy

113.40K

$11.33K

List of latest transactions for each holding click on a transaction to see Anton Gueth's performance on stock

See All Insider Trading from Today

Anton Gueth insider profile FAQ

What is the percentage of profitable transactions made by Anton Gueth?

The percentage of profitable transactions made by Anton Gueth is 75%.

What is the average return per transaction made by Anton Gueth?

The average return per transaction made by Anton Gueth is 84.30%.

What stocks does Anton Gueth hold?

Anton Gueth holds: ATRS, NAVB, SPPI stocks.

What was Anton Gueth’s latest transaction?

Anton Gueth latest transaction was an Uninformative Sell of $429.00K.

What was Anton Gueth's most profitable transaction?

Anton Gueth’s most profitable transaction was an Informative Buy of ATRS stock on March 21, 2016. The return on the trade was 231.60%.

What is Anton Gueth's role in Antares Pharma?

Anton Gueth's role in Antares Pharma is Director.

How can I follow the stock ratings of top corporate insiders?

Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

Anton Gueth Insider Profile

Anton Gueth Antares Pharma (ATRS)Director